home > epc > autumn 2019 > dispelling the fears of inspection
European Pharmaceutical Contractor

Dispelling the Fears of Inspection

When I was offered the opportunity to be a research coordinator in 2011, I immediately conjured up images of Frankensteinís lab: large, complicated equipment, mysterious liquids bubbling in the corner, all exciting stuff. However, it wasnít the trailblazing world I imagined. That isnít to say itís not interesting and incredibly worthwhile, and I am delighted that the world of GCP, governance, recruitment, and informed consent has turned out to be more exciting, dramatic, interesting, and rewarding than I ever envisioned. The experience I gained has been much more akin to a variation of an episode of Stranger Things than the scary world created by Mary Shelley.

I picked up some fundamental tips during my time coordinating a variety of both commercial and academic studies, some obvious, some maybe a little more specific. These may not cover everything required to make anyone (including me) the perfect coordinator, but they are important. If someone can adopt these basic traits, they will be well on their way to having a successful study with happy participants and sponsors.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:

There are no comments in regards to this article.

About the author

After nearly 20 years in the NHS, starting as a hospital porter, Ross Downes has been lucky enough to spend the best part of the last eight years working in the exciting world of research. The beginnings of this were spent on a steep learning curve as an ophthalmology research coordinator, before some time working in the incredibly diverse world of primary care. His current role as the Industry Manager for the NIHR, Thames Valley, and South Midlands Clinical Research Network enables Ross to help facilitate and integrate research into trusts within the region.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Northway Biotechpharma enters into Development and Manufacturing Agreement with Synklino

Vilnius, Lithuania, and Copenhagen, Denmark ‚Äď December 18th 2019 ‚Äď Northway Biotechpharma, a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), and Synklino, a company active in developing a therapeutic protein based therapy as treatment for cytomegalovirus (CMV) infection, announced today that they entered into a Development and Manufacturing Agreement for the recombinant fusion protein SYNx, which Synklino aims to bring into clinical trials.
More info >>

White Papers

Soothing the Logistical Headache of Clinical Trials

Equilibrium Travel Management

As many as 30 per cent of subjects on phase three clinical studies drop out.  Gruelling schedules, high travel costs and time waiting for expense reimbursement can all be factors in these fall rates, and this can be very problematic, delaying or even leading to the cancellation of the trial.  It is crucial to keep subjects motivated, and through efficient travel and expense management, this can be achieved.
More info >>

Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement